Picard F, et al. – This study was meant to examine the safety as well as efficacy of bioresorbable vascular scaffold (BVS) implantation to treat in-stent restenosis (ISR). As per real–world data, ISR treatment with ABSORB BVS was feasible but could have slightly higher target lesion failure rates as compared to drug-eluting stents (DES).